Table 2 Survival data.
From: Desmoplasia in cervical cancer is associated with a more aggressive tumor phenotype
Overall survival | n | 5-year OAS (%) | 95% CI | p value | Median follow-up in months (IQR) | |
|---|---|---|---|---|---|---|
All patients (n = 438) | 438 | 82.8 | 78.8–87.0 | 58 (32–74) | ||
All patients | No Desmoplasia | 85 | 94.5 | 89.3–99.9 | 0.015 | |
Weak desmoplasia | 141 | 82.1 | 75.0–89.8 | |||
Intermediate desmoplasia | 119 | 80.6 | 72.7–89.4 | |||
Strong desmoplasia | 93 | 76.8 | 67.8–87.0 | |||
pN0 | No Desmoplasia | 98.4 | 95.2–100 | 0.028 | ||
Desmoplasia | 88.6 | 84.6–93.4 | ||||
pN1 | No desmoplasia | 63.0 | 36.3–100 | 0.65 | ||
Desmoplasia | 50.0 | 39.3–63.6 |
Recurrence free survival | n | 5-year RFS | 95% CI | p value | Median follow-up in months (IQR) | |
|---|---|---|---|---|---|---|
All patients (n = 438) | 438 | 77.6 | 73.5–82.0 | 57 (31–73) | ||
All patients | No Desmoplasia | 85 | 87.3 | 79.7–95.6 | 0.037 | |
Weak desmoplasia | 141 | 78.5 | 71.5–86.2 | |||
Intermediate desmoplasia | 119 | 73.0 | 64.5–87.7 | |||
Strong desmoplasia | 93 | 73.0 | 64.0–83.2 | |||
pN0 | No Desmoplasia | 75 | 90.1 | 82.7–98.1 | 0.12 | |
Desmoplasia | 272 | 83.6 | 79.0–88.6 | |||
pN1 | No desmoplasia | 10 | 60.0 | 32.9–100 | 0.34 | |
Desmoplasia | 81 | 47.0 | 35.3–62.5 |
